Decreased striatal binding of radioactive tracers, as indicated by abnormal dopamine transporter activity on SPECT or PET imaging, has been shown to have good sensitivity and specificity to DLB [33], and is considered the most reliable biological diagnostic marker for this condition. This evidence concerns the gene SLC6A3 and Lewy body dementia.